Search results for abx831216

Ponezumab, Abbexa, abx831216

Ponezumab is a monoclonal antibody biosimilar expressed in CHO cells, targeting APP Abeta40, for use in laboratory research applications. This product is not suitable for use as medicines or in human, therapeutic or diagnostic applications. Ponezumab is under investigation in clinical trial NCT00607308 (A Phase I, Single Dose Study Of PF-04360365 In Japanese Patients With Mild To Moderate Alzheimer's Disease).